← Back to Dashboard

SUNPHARMA Sun Pharmaceutical Industries Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 1.66%
₹ 1,943.00
-0.96%
1-year price · range ₹1,579–₹1,962

Live setups screens SUNPHARMA is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about SUNPHARMA

In the last completed session, Sun Pharmaceutical Industries Ltd. closed +0.30% with futures open interest moving -0.5%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.54, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,900 sits 2.2% below the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Sun Pharmaceutical Industries Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Sun Pharmaceutical Industries Ltd. lacks a clear directional bias.

F&O Positioning EOD derivatives setup

Buildup Class
Neutral
bias: neutral
Futures OI
17,429,300
-82950 (-0.5%)
Option PCR (OI)
0.54
heavy call writing
Max Pain Strike
₹ 1,900
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,961.90
yesterday's EOD close
Index Contribution
-0.016 pp
contribution to Nifty
Traded Volume
1,718,430
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
61.5
neutral momentum
52-Week High
₹ 1,966.50
-1.2% from high
52-Week Low
₹ 1,548.00
+25.5% above low
200-DMA
₹ 1,764.91
+10.1% · above trend
50-DMA
₹ 1,862.93
+4.3% from 50-DMA
1-Year Return
+14.1%
1M +4.0%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
40.6
price / earnings
P/B
5.6
price / book
ROE
14.7%
return on equity
Market Cap
₹ 466,191 Cr
total market value
Dividend Yield
0.82%
trailing yield
EPS (TTM)
₹ 47.87
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

Date Side Price Value (Cr) Counterparty
2026-06-24 BUY ₹ 1,868.00 28.85 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794
2026-06-24 SELL ₹ 1,868.00 28.85 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-07-28 · spot 1,962 · EOD 2026-07-21

Option writers expect range between 1,900 and 1,960-0.1% upside, -3.2% downside.
unbalanced
Call OI (writers) Strike Put OI (writers)
84,350 -8k
1840
233,450 -4k
178,150 -1k
1860
250,600 +8k
247,800 -59k
1880
419,650 -42k
1,782,550 -14k
1900 S MP
963,200 -4k
685,650 -68k
1920
536,200 -105k
IV 20% Δ -0.18 θ -1.0 ν 1
1,458,100 +69k
IV 14% Δ 0.76 θ -1.2 ν 1
1940
724,150 +39k
IV 20% Δ -0.31 θ -1.4 ν 1
2,829,400 -16k
IV 15% Δ 0.55 θ -1.5 ν 1
1960 R
498,050 +29k
IV 21% Δ -0.46 θ -1.6 ν 1
1,280,300 +1k
IV 17% Δ 0.36 θ -1.4 ν 1
1980
350,700 +56k
IV 22% Δ -0.61 θ -1.6 ν 1
997,850 +11k
IV 19% Δ 0.23 θ -1.3 ν 1
2000
143,850 +9k
IV 25% Δ -0.71 θ -1.5 ν 1
302,400 -15k
IV 21% Δ 0.15 θ -1.1 ν 1
2020
8,750
IV 59% Δ -0.63 θ -4.4 ν 1
311,150 +67k
2040
10,500
IV 29% Δ -0.84 θ -1.2 ν 1
87,850 -5k
2060
0
IV 160% Δ -0.55 θ -13.0 ν 1
71,750 -23k
2080
6,300
IV 30% Δ -0.93 θ -0.5 ν 0

Chain Interpretation

Spot Underlying 1,961.90
Key Resistance (R) 1,960
Key Support (S) 1,900
Max Pain Strike (MP) 1,900
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for SUNPHARMA options · 2026-07-28 expiry

Underlying: SUNPHARMA · Spot: ₹ 1,961.90 · Expiry: 2026-07-28 · Lot: 350

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

SUNPHARMA — frequently asked questions

What is the Sun Pharmaceutical Industries Ltd. share price today?

SUNPHARMA is trading at ₹1,943.00 (-0.96% vs previous close), per the latest update on this page.

What is the P/E ratio of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA (Sun Pharmaceutical Industries Ltd.) has a trailing twelve-month P/E ratio of 40.6.

What is the market cap of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA has a market capitalisation of approximately ₹466,191 crore.

What is the ROE of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA has a return on equity (ROE) of about 14.7%.

Is SUNPHARMA near its 52-week high?

SUNPHARMA is trading -1.2% from its 52-week high of ₹1,966.50 as of 2026-07-22.

What is the RSI of SUNPHARMA?

The 14-day RSI of SUNPHARMA is 61.5, which is considered neutral.

Is SUNPHARMA above its 200-day moving average?

SUNPHARMA is trading above its 200-DMA of ₹1,764.91 (+10.1% away).

What is the F&O buildup in SUNPHARMA?

The latest end-of-day derivatives data classifies SUNPHARMA as Neutral (bias: neutral), based on the day's combined price and open-interest change.

What is the max pain and PCR for SUNPHARMA options?

SUNPHARMA's option-chain max pain strike is ₹1,900 and its put-call ratio (OI) is 0.54, from the latest end-of-day option chain.

Are FIIs or big investors buying SUNPHARMA?

Strota tracks every bulk and block deal in SUNPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.